Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garraway

Showing results (371-380 of 549) with videos related to

Pageof 55
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndre P Fay, Guillermo de Velasco, Thai H Ho, et al.
Molecular Cell|November 27, 2010
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanomaCarmit Levy, Mehdi Khaled, Dimitrios Iliopoulos, et al.
Molecular Cancer Therapeutics|February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setEun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
The Journal of Investigative Dermatology|September 2, 2011
Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patientsWilliam M Lin, Julia M Lewis, Renata B Filler, et al.
Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.
The Oncologist|March 31, 2010
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoverySabine Tejpar, Monica Bertagnolli, Fred Bosman, et al.
Nature Genetics|October 27, 2014
RNF43 is frequently mutated in colorectal and endometrial cancersMarios Giannakis, Eran Hodis, Xinmeng Jasmine Mu, et al.
Cancer Research|July 5, 2005
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysisXiaojun Zhao, Barbara A Weir, Thomas LaFramboise, et al.
Pageof 55

Showing results (371-380 of 549) with videos related to

Sort By:
Pageof 55
Journal of the National Comprehensive Cancer Network : JNCCN|July 14, 2016
Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell CarcinomaAndre P Fay, Guillermo de Velasco, Thai H Ho, et al.
Molecular Cell|November 27, 2010
Intronic miR-211 assumes the tumor suppressive function of its host gene in melanomaCarmit Levy, Mehdi Khaled, Dimitrios Iliopoulos, et al.
Molecular Cancer Therapeutics|February 4, 2010
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line setEun Sung Park, Rosalia Rabinovsky, Mark Carey, et al.
JAMA Network Open|March 19, 2024
Neighborhood Deprivation, Race and Ethnicity, and Prostate Cancer Outcomes Across California Health Care SystemsAnanta Wadhwa, Charlotte Roscoe, Elizabeth A Duran, et al.
Cancer Research|February 18, 2010
An oncogenic role for ETV1 in melanomaJudit Jané-Valbuena, Hans R Widlund, Sven Perner, et al.
The Journal of Investigative Dermatology|September 2, 2011
Characterization of the DNA copy-number genome in the blood of cutaneous T-cell lymphoma patientsWilliam M Lin, Julia M Lewis, Renata B Filler, et al.
Blood|January 7, 2011
High-throughput mutation profiling of CTCL samples reveals KRAS and NRAS mutations sensitizing tumors toward inhibition of the RAS/RAF/MEK signaling cascadeMichael K Kiessling, Patrick A Oberholzer, Chandrani Mondal, et al.
The Oncologist|March 31, 2010
Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discoverySabine Tejpar, Monica Bertagnolli, Fred Bosman, et al.
Nature Genetics|October 27, 2014
RNF43 is frequently mutated in colorectal and endometrial cancersMarios Giannakis, Eran Hodis, Xinmeng Jasmine Mu, et al.
Cancer Research|July 5, 2005
Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysisXiaojun Zhao, Barbara A Weir, Thomas LaFramboise, et al.
Pageof 55